Veracyte, Inc. (VCYT): Price and Financial Metrics
Veracyte, Inc. (VCYT)
Today's Latest Price: $57.62 USD
Updated Dec 4 4:00pm
Add VCYT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
VCYT Stock Summary
- VCYT's price/sales ratio is 28.3; that's higher than the P/S ratio of 93.21% of US stocks.
- VCYT's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of just 9.78% of US stocks.
- Over the past twelve months, VCYT has reported earnings growth of 378.87%, putting it ahead of 96.11% of US stocks in our set.
- If you're looking for stocks that are quantitatively similar to Veracyte Inc, a group of peers worth examining would be INSP, ATRC, EB, MTBC, and UPWK.
- VCYT's SEC filings can be seen here. And to visit Veracyte Inc's official web site, go to www.veracyte.com.
VCYT Stock Price Chart Interactive Chart >
VCYT Price/Volume Stats
| Current price | $57.62 | 52-week high | $58.00 |
| Prev. close | $55.90 | 52-week low | $13.90 |
| Day low | $55.13 | Volume | 569,500 |
| Day high | $58.00 | Avg. volume | 512,555 |
| 50-day MA | $42.51 | Dividend yield | N/A |
| 200-day MA | $31.03 | Market Cap | 3.34B |
Veracyte, Inc. (VCYT) Company Bio
Veracyte Inc. operates as a molecular diagnostics company in the United States. It operates in the field of molecular cytology with genomic solutions that resolve diagnostic ambiguity and enable physicians to make informed treatment decisions at an early stage in patient care. The company was founded in 2006 and is based in San Francisco, California.
Loading social stream, please wait...